Anyone 'for' this stock is just the paid hypers/stock promoters left in this forum it looks like.
Nothing has changed, continued pay outs to Adam Blumanethal and I'm assuming the companies financial report hasn't changed in the last 2 years (not spending the time reading through it), meaning siphoning money into their own pockets and excessive expenses on basically fluff to cover up their payments to themselves - Nothing to see here, this should be sub 3c by end of the year where it (may) be fair value, or at least much fairer than now.
- Forums
- ASX - By Stock
- CPH
- Creso Pharma (ASX:CPH) grows revenue and market presence in Q4
Creso Pharma (ASX:CPH) grows revenue and market presence in Q4, page-15
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online